| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5656461 | HPB | 2017 | 7 Pages |
Abstract
Patients with resectable CLM should be offered PSH if technically feasible. PSH is safer than MH without compromising long-term survival.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Jeffrey T. Lordan, John K. Roberts, James Hodson, John Isaac, Paolo Muiesan, Darius F. Mirza, Ravi Marudanayagam, Robert P. Sutcliffe,